PTPN22 rs2488389: Autoimmune Risk and Genetic Variation
The rs2488389 single nucleotide polymorphism is a non-coding regulatory variant located in the promoter region of the PTPN22 gene on chromosome 1. Genome-wide association studies and candidate gene screens have linked this variant to altered susceptibility to complex autoimmune disorders, including type 1 diabetes and rheumatoid arthritis. However, because it acts as a subtle modulator rather than a direct causative mutation, evidence for its independent clinical impact remains limited.
What each genotype means
Typical genetic baseline
This genotype represents the most common version of the PTPN22 promoter region found in the general population. Research indicates that individuals with this profile do not carry the specific genetic variation associated with increased susceptibility to certain autoimmune conditions linked to this gene.
This is the most frequent genotype observed in European populations.
Increased autoimmune risk marker
Carrying one copy of the T allele at this location has been associated in some studies with a slightly altered risk for autoimmune conditions, such as type 1 diabetes or rheumatoid arthritis. Because this association is based on statistical trends across large populations, it does not predict the development of any disease for an individual.
This genotype is found in a significant portion of individuals of European ancestry, reflecting the common nature of this variant.
Elevated autoimmune risk marker
Individuals with two copies of the T allele may show a stronger statistical association with susceptibility to certain autoimmune disorders compared to those without the variant. This finding is based on population-level data and should be viewed as one of many factors that contribute to immune system function rather than a diagnostic indicator.
This genotype is less common than the heterozygous state but is still regularly identified in European populations.
Genomic Location and Variant Characteristics
The single nucleotide polymorphism rs2488389 is situated on chromosome 1 within the 5-prime upstream promoter region of the PTPN22 gene. In scientific databases such as dbSNP and Ensembl, the variant represents a common bi-allelic single nucleotide change (predominantly G to C on the genomic forward strand, with the minor allele often designated as C or alternatively G depending on reference strand orientation). Unlike missense mutations that directly modify the amino acid sequence of a protein, rs2488389 resides within non-coding regulatory DNA. Consequently, it does not alter protein structure but is hypothesized to influence transcription factor binding affinity, transcriptional efficiency, or the overall expression levels of the PTPN22 transcript in immune cells. Because it is positioned in an active regulatory segment, researchers frequently evaluate rs2488389 alongside neighboring promoter markers to investigate how non-coding regulatory architecture influences human immune homeostasis.
Biological Role of the PTPN22 Gene
The PTPN22 gene encodes lymphoid phosphatase (often abbreviated as Lyp), a non-receptor protein tyrosine phosphatase primarily expressed in hematopoietic cells. Lyp serves as a pivotal negative regulator of immune cell signaling, dampening the activation cascades triggered by T-cell receptors (TCR) and B-cell receptors (BCR). By dephosphorylating key signaling kinases such as Lck, Fyn, and ZAP-70, Lyp helps establish immune tolerance, preventing hyperactive lymphocyte activation against healthy host tissues. Proper regulation of PTPN22 expression is vital for calibrating the threshold between an effective immune response against foreign pathogens and the prevention of autoimmune reactivity. Alterations in PTPN22 expression levels or catalytic function can perturb the deletion of self-reactive lymphocytes, subtly shifting an individual's baseline immunological tolerance.
Autoimmune Associations and Evidence Strength
Multiple candidate gene investigations and genome-wide association studies (GWAS) have reported statistical associations between rs2488389 and altered risk for various autoimmune conditions, most prominently type 1 diabetes, rheumatoid arthritis, and juvenile idiopathic arthritis. While the coding variant PTPN22 rs2476601 (R620W) represents one of the strongest non-HLA genetic risk factors for autoimmunity in European cohorts, rs2488389 has been investigated both as a contributing regulatory risk factor and as an alternative marker in populations where rs2476601 is rare. Despite these findings, the scientific evidence supporting an independent, causative effect for rs2488389 is formally categorized as limited. Strong linkage disequilibrium across the extended PTPN22 locus makes it challenging to disentangle whether rs2488389 exerts an autonomous biological effect or simply tags a broader ancestral risk haplotype.
Population Distribution and Ancestral Patterns
Allele frequencies for rs2488389 exhibit measurable differences across worldwide populations documented in genomic catalogs like gnomAD. In individuals of European ancestry, the minor allele frequency typically ranges between 0.20 and 0.35, making heterozygous and homozygous minor genotypes common in these communities. Frequency patterns vary noticeably across global ancestries, with distinct distribution curves observed between East Asian, South Asian, African, and European cohorts. These demographic variations highlight the importance of evaluating genetic background when analyzing complex disease associations. A statistical association identified in one ancestral background does not automatically translate to identical risk magnitudes across diverse populations due to differing linkage disequilibrium structures and environmental modifiers.
Translating Research Into Everyday Context
Discovering an association between rs2488389 and autoimmune susceptibility provides valuable scientific insight into human immune biology, but it cannot be used to diagnose or predict clinical disease. Complex conditions like type 1 diabetes and rheumatoid arthritis are polygenic and multifactorial, driven by dozens of low-effect genetic loci, prominent HLA alleles, and environmental triggers. Carrying an associated allele at rs2488389 does not mean an individual will develop an autoimmune disorder, nor does possessing protective alleles guarantee immunity. This information should never be used to alter medical regimens or self-diagnose symptoms. Anyone with questions regarding family history or persistent physical symptoms should consult a qualified physician or clinical geneticist.
How common is this variant?
According to gnomAD data, the minor allele frequency for rs2488389 is approximately 0.20 to 0.35 in European populations, with significant variation seen across other continental ancestries.
Frequently asked questions
Does having the rs2488389 variant mean I will get type 1 diabetes or arthritis?
No. The rs2488389 variant is a common genetic marker that confers only a modest statistical shift in risk within large population studies. Complex autoimmune disorders depend on interactions between dozens of genetic loci and environmental factors, meaning the vast majority of carriers never develop these conditions.
What is the primary function of the PTPN22 gene?
PTPN22 produces lymphoid phosphatase (Lyp), an enzyme that dampens signaling in T and B lymphocytes. This inhibition helps calibrate the immune system to recognize foreign invaders while preventing healthy self-tissue from being mistakenly attacked.
How does rs2488389 differ from the well-known PTPN22 R620W variant?
While R620W (rs2476601) is a coding variant that directly changes an amino acid in the Lyp protein, rs2488389 is located in the non-coding promoter region. Rather than altering the protein structure, rs2488389 is thought to potentially influence how much of the protein is produced.
Can a doctor use rs2488389 to guide medical treatments?
No, clinical guidelines do not currently use rs2488389 to diagnose autoimmune disease or guide drug therapy. Genetic testing for common non-coding variants is primarily a research tool rather than a standalone clinical diagnostic.
Sources & further reading
Educational information only, last refreshed 9/7/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2488389?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in PTPN22
This variant in PTPN22 is associated with autoimmune-related phenotypes in patients with chronic spontaneous urticaria.
This variant in the PTPN22 gene region is associated with altered risk for autoimmune conditions including type 1 diabetes and rheumatoid arthritis.
Potent autoantigen-signaling variant R620W strongly associated with susceptibility to rheumatoid arthritis, type 1 diabetes, and systemic lupus erythematosus.
This variant is a major risk factor for several autoimmune diseases, including type 1 diabetes and rheumatoid arthritis.
The C/C genotype at this locus is linked to the downregulation of PTPN22 mRNA expression and increased rheumatoid arthritis risk.